Increased Expression of NKX3.1 in Benign Prostatic Hyperplasia

Urology

Volumn 73, Issue 5, 2009, Pages 1140-1144

  Irer, Bora ^a   Toylu, Asli ^a   Aslan, Guven ^a   Celebi, Ilhan ^a   Yorukoglu, Kutsal ^a   Atabey, Nese ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NKX3.1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLADDER NECK STENOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; GENE; GENE EXPRESSION REGULATION; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION; WESTERN BLOTTING;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BLOTTING, WESTERN; CHI-SQUARE DISTRIBUTION; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROBABILITY; PROSTATIC HYPERPLASIA; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; YOUNG ADULT;

EID: 65049088078     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.02.039     Document Type: Article

References (25)

1. Ziada A., Rosenblum M., and Crawford E.D. Benign prostatic hyperplasia: an overview. Urology 53 (1999) 1-6
2. Eaton C.L. Aetiology and pathogenesis of benign prostatic hyperplasia. Curr Opin Urol 13 (2003) 7-10
3. Berry S.J., Coffey D.S., Walsh P.C., et al. The development of human benign prostatic hyperplasia with age. J Urol 132 (1984) 474-479
4. Mullan R.J., Bergstralh E.J., Farmer S.A., et al. Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology 67 (2006) 300-305
5. Marcelli M., and Cunningham G.R. Hormonal signaling in prostatic hyperplasia and neoplasia. J Clin Endocrinol Metab 84 (1999) 3463-3468
6. Trapman J., and Cleutjens K.B. Androgen-regulated gene expression in prostate cancer. Semin Cancer Biol 8 (1997) 29-36
7. Kim Y., and Nirenberg M. Drosophila NK-homeobox genes (NK-1, NK-2, NK-3, and NK-4 DNA clones/chromosome locations of genes). Proc Natl Acad Sci U S A 86 (1989) 7716-7720
8. He W.W., Sciavolino P.J., Wing J., et al. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 43 (1997) 69-77
9. Bhatia-Gaur R., Donjacour A.A., Sciavolino P.J., et al. Roles for Nkx3.1 in prostate development and cancer. Genes Dev 13 (1999) 966-977
10. Voeller H.J., Augustus M., Madike V., et al. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res 57 (1997) 4455-4459
11. Ornstein D.K., Cinquanta M., Weiler S., et al. Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium. J Urol 165 (2001) 1329-1334
12. Korkmaz C.G., Korkmaz K.S., Onody T., et al. Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis. J Urol 172 (2004) 1134-1139
13. Bowen C., Bubendorf L., Voeller H.J., et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 60 (2000) 6111-6115
14. Aslan G., Irer B., Tuna B., et al. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features. Pathol Res Pract 202 (2006) 93-98
15. Asatiani E., Huang W.X., Wang A., et al. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 65 (2005) 1164-1173
16. Ortner E.R., Hayes R., Weissfeld J., et al. Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size. Urology 67 (2006) 311-315
17. Schwartz Jr. S., Caceres C., Morote J., et al. Over-expression of epidermal growth factor receptor and c-erbB2/neu but not of int-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR. Int J Cancer 76 (1998) 464-467
18. Tiniakos D.G., Mitropoulos D., Kyroudi-Voulgari A., et al. Expression of c-jun oncogene in hyperplastic and carcinomatous human prostate. Urology 67 (2006) 204-208
19. Luo J., Dunn T., Ewing C., et al. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. Prostate 51 (2002) 189-200
20. Warot X., Fromental-Ramain C., Fraulob V., et al. Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 124 (1997) 4781-4791
21. Economides K.D., and Capecchi M.R. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development 130 (2003) 2061-2069
22. Bieberich C.J., Fujita K., He W.W., et al. Prostate-specific and androgen dependent expression of a novel homeobox gene. J Biol Chem 271 (1996) 31779-31782
23. Gelmann E.P., Bowen C., and Bubendorf L. Expression of NKX3.1 in normal and malignant tissues. Prostate 55 (2003) 111-117
24. Shen M.M., and Abate-Shen C. Roles of the NKX3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 228 (2003) 767-778
25. Korkmaz K.S., Korkmaz C.G., Ragnhildstveit E., et al. Full-length cDNA sequence and genomic organization of human NKX3a-alternative forms and regulation by both androgens and estrogens. Gene 260 (2000) 25-36